Evolent Health Inc (EVH) USD0.01

Sell:$20.86Buy:$20.87$0.75 (3.45%)

Prices delayed by at least 15 minutes
Sell:$20.86
Buy:$20.87
Change:$0.75 (3.45%)
Prices delayed by at least 15 minutes
Sell:$20.86
Buy:$20.87
Change:$0.75 (3.45%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
2 March 2024
Daniel Joseph (Dan) McCarthyPresident
Sell
Tax related
5,638$34.41$194,003.58217,952
2 March 2024
John Paul JohnsonCFO
Sell
Tax related
9,020$34.41$310,378.20215,900
2 March 2024
Jonathan D. WeinbergGeneral Counsel
Sell
Tax related
4,830$34.41$166,200.30167,027
1 March 2024
Seth BlackleyChairman/CEO
Sell
Tax related
24,005$34.41$826,012.05760,382
1 March 2024
John Paul JohnsonCFO
Sell
Tax related
11,213$34.41$385,839.33224,920
1 March 2024
Daniel Joseph (Dan) McCarthyPresident
Sell
Tax related
13,210$34.41$454,556.10223,590
1 March 2024
Jonathan D. WeinbergGeneral Counsel
Sell
Tax related
7,460$34.41$256,698.60171,857
1 March 2024
Emily Ann RaffertyCOO
Sell
Tax related
7,049$34.41$242,556.0972,269
1 March 2024
Aammaad ShamsController/Treasurer
Sell
Tax related
2,569$34.41$88,399.2954,946
22 February 2024
Seth BlackleyChairman/CEO
Sell
Tax related
88,563$33.03$2,925,235.89755,291

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
22 February 2024
Seth BlackleyChairman/CEO
Sell
Tax related
88,563$33.03$2,925,235.89755,291
5 December 2023
Seth BlackleyChairman/CEO
Sell
Tax related
92,616$26.61$2,464,511.76658,545
1 March 2024
Seth BlackleyChairman/CEO
Sell
Tax related
24,005$34.41$826,012.05760,382
5 December 2023
Seth BlackleyChairman/CEO
Sell
Tax related
27,484$25.74$707,438.16751,161
22 February 2024
John Paul JohnsonCFO
Sell
Tax related
20,006$33.03$660,798.18224,010

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.